West Pharmaceutical Services | WST - Sales Revenues

Stock Price
304.08
Daily Change
1.19 0.39%
Monthly
9.38%
Yearly
39.99%
Q2 Forecast
296.80

West Pharmaceutical Services reported $844.9M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Align Technology USD 1.04B 10M Mar/2026
Avanos Medical USD 182.2M 1.3M Mar/2026
Baxter International USD 2.7B 270M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Cerus USD 50.81M 4.79M Dec/2024
Charles River Laboratories USD 995.8M 1.6M Mar/2026
Cooper Companies USD 1.02B 41.1M Dec/2025
Dentsply International USD 880M 81M Mar/2026
Haemonetics USD 346M 7.03M Mar/2026
ICU Medical USD 525.77M 14.93M Mar/2026
Insulet USD 761.7M 22.1M Mar/2026
Integra LifeSciences USD 391.9M 43M Mar/2026
IQVIA Holdings USD 4.15B 210M Mar/2026
J&J USD 24.1B 500M Mar/2026
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 381.9M 12M Mar/2026
Neogen USD 211.2M 13.49M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Quidel USD 620M 104M Mar/2026
Repligen USD 194M 3.91M Mar/2026
Rockwell Medical USD 25.83M 3.15M Jun/2024
Solventum Corp USD 2.01B 20M Mar/2026
STAAR Surgical USD 93.5M 145.9M Mar/2026
Terumo JPY 300.32B 3.69B Mar/2026
Utah Medical Products USD 9.04M 955K Dec/2025
West Pharmaceutical Services USD 844.9M 39.9M Mar/2026